
Sign up to save your podcasts
Or


On Monday, the FTC told Illumina to dissolve their acquisition with the multi-cancer early detection test company Grail. David Lim talks with host Ben Leonard about what this move means for the development and commercialization of cancer tests in the United States.
Learn more about your ad choices. Visit megaphone.fm/adchoices
By POLITICO4.7
453453 ratings
On Monday, the FTC told Illumina to dissolve their acquisition with the multi-cancer early detection test company Grail. David Lim talks with host Ben Leonard about what this move means for the development and commercialization of cancer tests in the United States.
Learn more about your ad choices. Visit megaphone.fm/adchoices

610 Listeners

1,526 Listeners

706 Listeners

112,063 Listeners

964 Listeners

307 Listeners

56,553 Listeners

102 Listeners

495 Listeners

207 Listeners

648 Listeners

6,445 Listeners

138 Listeners

386 Listeners

41 Listeners

11 Listeners

743 Listeners